Iran Press/Iran news: The opening ceremony was held with the attendance of Hojjatoleslam Raissi, Chief official of Astan Qods Razavi in northeastern Iran.
By launching the production line in a new section of "Saman daroo 8" Pharmaceutical Company, the Islamic Republic of Iran will be among the first five countries in the world to be able to treat hemophiliacs.
Based on the research of the knowledge-based companies, Factor VIII is a new way of treating hemophilia patients, and Iran is among the first five countries in the world that owns the technology.
Factor VIII is derived from concentrated donated blood plasma, and can be given to hemophiliacs to restore their hemostasis.
In the first stage, the medicine (Factor VIII) will be used to treat hemophiliacs in Iran, and in the next stage the new medicine will be exported to regional countries.
213/ 211
